Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors

The present invention relates to novel N,9-disubstituted adenine derivatives and novel aristeromycin analogues which are further substituted at the adenine 2-position, and which have a hydroxymethyl group, or an ester or ester isostere at a position corresponding to the ribose 4-position, and pharma...

Full description

Saved in:
Bibliographic Details
Main Authors DAVID R. VARLEY, UFFE BANG OLSEN, LARS KNUTSEN, STANLEY M. ROBERTS, ANDREW NEIL BOWLER
Format Patent
LanguageEnglish
Published 02.02.1998
Edition6
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Online AccessGet full text

Cover

Abstract The present invention relates to novel N,9-disubstituted adenine derivatives and novel aristeromycin analogues which are further substituted at the adenine 2-position, and which have a hydroxymethyl group, or an ester or ester isostere at a position corresponding to the ribose 4-position, and pharmaceutically acceptable addition salts thereof. The compounds act as cytokine inhibitors. Also covered are processes for preparation of the above derivatives and their pharmaceutical compositions as well as methods for using the compounds and compositions as drugs for the treatment of disorders involving cytokines in humans.
AbstractList The present invention relates to novel N,9-disubstituted adenine derivatives and novel aristeromycin analogues which are further substituted at the adenine 2-position, and which have a hydroxymethyl group, or an ester or ester isostere at a position corresponding to the ribose 4-position, and pharmaceutically acceptable addition salts thereof. The compounds act as cytokine inhibitors. Also covered are processes for preparation of the above derivatives and their pharmaceutical compositions as well as methods for using the compounds and compositions as drugs for the treatment of disorders involving cytokines in humans.
Author ANDREW NEIL BOWLER
STANLEY M. ROBERTS
DAVID R. VARLEY
LARS KNUTSEN
UFFE BANG OLSEN
Author_xml – fullname: DAVID R. VARLEY
– fullname: UFFE BANG OLSEN
– fullname: LARS KNUTSEN
– fullname: STANLEY M. ROBERTS
– fullname: ANDREW NEIL BOWLER
BookMark eNrjYmDJy89L5WRw9MsvS81R0MjT1E3Myc6vqExMSc3LzEtVSEktyixLLMksSy1WSEwuycxLV0gsVkiuLMnPBkln5mVkJmWW5BcV8zCwpiXmFKfyQmluBnk31xBnD93Ugvz41OKCxOTUvNSSeMdQYyNTUwNLc0djwioAVgky1w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID AU3255097A
GroupedDBID EVB
ID FETCH-epo_espacenet_AU3255097A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:48:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU3255097A3
Notes Application Number: AU19970032550
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980202&DB=EPODOC&CC=AU&NR=3255097A
ParticipantIDs epo_espacenet_AU3255097A
PublicationCentury 1900
PublicationDate 19980202
PublicationDateYYYYMMDD 1998-02-02
PublicationDate_xml – month: 02
  year: 1998
  text: 19980202
  day: 02
PublicationDecade 1990
PublicationYear 1998
RelatedCompanies NOVO-NORDISK A/S
RelatedCompanies_xml – name: NOVO-NORDISK A/S
Score 2.4804735
Snippet The present invention relates to novel N,9-disubstituted adenine derivatives and novel aristeromycin analogues which are further substituted at the adenine...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Title Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980202&DB=EPODOC&locale=&CC=AU&NR=3255097A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOpNUYPfO5hFD4uwbgMOixn7CDFhEAOGG-nWThZIR9xE-e99m0y9kPTQ9DVN2_TX917b3yvAHWlyrUVVokQsihSNM0NpE4a4YhzVpdHQNJY7in3f6I2154k-qcCs5MIUcUI_i-CIiKgQ8Z4V-_Xy7xDLKd5Wpo9BjEXJkzcyHZmVdDG0flTZ6ZrucOAMbNm20ZOU_ReToOnc6LSsHdjFXCvHgvvazTkpy_8KxTuCvSG2JbJjqHBRgwO7_HetBvv9zXU3ZjfIS0_A8pMVX0j34kGhi3nytaa4YWAlieESWhXRu1MpJymIN4mmUrjOknkujsUsDuL8S51TuPXckd1TsC_T32FPrXHZaXIGVZEIXgcpQpdDJdTQI9LRWIe2UQPpURCi4UWpwfRzqG9r5WK76BIOf7h2KqYrqGbvH_walW0W3BTz9A2qmYUP
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOJNUYM_2cEseliEdRtwIAY2CCobxAzDjXS0kwXSETdR_nvfJlMvJD00fU3TNv363mv7vQLckCrXalQlis98X9E4M5Q6YYgrxlFdGhVNY4mjaDtGb6Q9jfVxDmYZFyaNE_qZBkdERE0R73G6Xy__DrGs9G1ldO8FWBQ-dN2mJbOMLobWjypb7WZnOLAGpmya6EnKzkuToOlcadRaO7CLBnYtwULntZ1wUpb_FUr3EPaG2JaIjyDHRREKZvbvWhH27c11N2Y3yIuOoeWEK76QbsWdQhfz8GtNccPAShLDJbRKo3dHUkJSEG8SjaTpOg7niTgQs8ALki91TqDc7bhmT8G-TH6HPWmNsk6TU8iLUPASSD66HCqhhu6ThsYatI4aSPe9KRpelBpMP4PStlbOt4vKUOi5dn_Sf3SeL-Dgh3enYrqEfPz-wa9Q8cbedTpn3xL4iAI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+%28n%29-alkoxyadenine+derivatives+acting+as+cytokine+inhibitors&rft.inventor=DAVID+R.+VARLEY&rft.inventor=UFFE+BANG+OLSEN&rft.inventor=LARS+KNUTSEN&rft.inventor=STANLEY+M.+ROBERTS&rft.inventor=ANDREW+NEIL+BOWLER&rft.date=1998-02-02&rft.externalDBID=A&rft.externalDocID=AU3255097A